CN114807078A - 一种生物合成nmn的方法 - Google Patents
一种生物合成nmn的方法 Download PDFInfo
- Publication number
- CN114807078A CN114807078A CN202210408487.1A CN202210408487A CN114807078A CN 114807078 A CN114807078 A CN 114807078A CN 202210408487 A CN202210408487 A CN 202210408487A CN 114807078 A CN114807078 A CN 114807078A
- Authority
- CN
- China
- Prior art keywords
- gene
- nmn
- nicotinamide
- escherichia coli
- pncc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000002194 synthesizing effect Effects 0.000 title abstract description 8
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 claims abstract description 74
- 101150017231 pncC gene Proteins 0.000 claims abstract description 41
- 241000588724 Escherichia coli Species 0.000 claims abstract description 37
- 101150043139 nadR gene Proteins 0.000 claims abstract description 36
- 101150111394 nadD gene Proteins 0.000 claims abstract description 35
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 32
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 26
- 241000894006 Bacteria Species 0.000 claims abstract description 21
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims abstract description 19
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 19
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 16
- 239000011570 nicotinamide Substances 0.000 claims abstract description 16
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 101100523877 Mus musculus Rbks gene Proteins 0.000 claims abstract description 12
- 101150049023 nadE gene Proteins 0.000 claims abstract description 12
- 108091000080 Phosphotransferase Proteins 0.000 claims abstract description 9
- 102000020233 phosphotransferase Human genes 0.000 claims abstract description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 5
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 5
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 239000013598 vector Substances 0.000 claims description 17
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 15
- 101150108007 prs gene Proteins 0.000 claims description 11
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 101150016674 prs2 gene Proteins 0.000 claims description 9
- 102000000780 Nicotinate phosphoribosyltransferase Human genes 0.000 claims description 8
- 108700040046 Nicotinate phosphoribosyltransferases Proteins 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000003209 gene knockout Methods 0.000 claims description 7
- 108090000992 Transferases Proteins 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 102000004357 Transferases Human genes 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000010353 genetic engineering Methods 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229950006238 nadide Drugs 0.000 claims 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims 3
- 108700023418 Amidases Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000005922 amidase Human genes 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 16
- 108090000790 Enzymes Proteins 0.000 abstract description 16
- 230000003197 catalytic effect Effects 0.000 abstract description 9
- 230000006696 biosynthetic metabolic pathway Effects 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 6
- 239000003054 catalyst Substances 0.000 abstract description 3
- 108010024137 Nicotinamide-Nucleotide Adenylyltransferase Proteins 0.000 abstract description 2
- 108010044472 Nicotinamide-nucleotide amidase Proteins 0.000 abstract description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 23
- 108020004414 DNA Proteins 0.000 description 22
- 239000012634 fragment Substances 0.000 description 13
- 238000010276 construction Methods 0.000 description 12
- 238000012216 screening Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000006555 catalytic reaction Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000010362 genome editing Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JLEBZPBDRKPWTD-TURQNECASA-O N-ribosylnicotinamide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=C1 JLEBZPBDRKPWTD-TURQNECASA-O 0.000 description 6
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 6
- 108091027544 Subgenomic mRNA Proteins 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 108091033409 CRISPR Proteins 0.000 description 5
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000001131 transforming effect Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229960000268 spectinomycin Drugs 0.000 description 3
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000010354 CRISPR gene editing Methods 0.000 description 2
- 241000589602 Francisella tularensis Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108020005004 Guide RNA Proteins 0.000 description 2
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 108020000772 Ribose-Phosphate Pyrophosphokinase Proteins 0.000 description 2
- 102000000439 Ribose-phosphate pyrophosphokinase Human genes 0.000 description 2
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- FZAQROFXYZPAKI-UHFFFAOYSA-N anthracene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC3=CC(S(=O)(=O)Cl)=CC=C3C=C21 FZAQROFXYZPAKI-UHFFFAOYSA-N 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229940118764 francisella tularensis Drugs 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- IHADVZPGQYQGLH-QXRNQMCJSA-N (4r,5r,6r)-4,5,6,7-tetrahydroxyheptane-2,3-dione Chemical compound CC(=O)C(=O)[C@H](O)[C@H](O)[C@H](O)CO IHADVZPGQYQGLH-QXRNQMCJSA-N 0.000 description 1
- SCPRYBYMKVYVND-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)CC(N)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(O)=O SCPRYBYMKVYVND-UHFFFAOYSA-N 0.000 description 1
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- RUXQNKVQSKOOBS-JURCDPSOSA-N Ala-Phe-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RUXQNKVQSKOOBS-JURCDPSOSA-N 0.000 description 1
- CQJHFKKGZXKZBC-BPNCWPANSA-N Ala-Pro-Tyr Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CQJHFKKGZXKZBC-BPNCWPANSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- MTDDMSUUXNQMKK-BPNCWPANSA-N Ala-Tyr-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N MTDDMSUUXNQMKK-BPNCWPANSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- ZTKHZAXGTFXUDD-VEVYYDQMSA-N Arg-Asn-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZTKHZAXGTFXUDD-VEVYYDQMSA-N 0.000 description 1
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 1
- SYAUZLVLXCDRSH-IUCAKERBSA-N Arg-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N SYAUZLVLXCDRSH-IUCAKERBSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 1
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 1
- AEZCCDMZZJOGII-DCAQKATOSA-N Asn-Met-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O AEZCCDMZZJOGII-DCAQKATOSA-N 0.000 description 1
- YHXNKGKUDJCAHB-PBCZWWQYSA-N Asn-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O YHXNKGKUDJCAHB-PBCZWWQYSA-N 0.000 description 1
- DATSKXOXPUAOLK-KKUMJFAQSA-N Asn-Tyr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DATSKXOXPUAOLK-KKUMJFAQSA-N 0.000 description 1
- HOQGTAIGQSDCHR-SRVKXCTJSA-N Asp-Asn-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HOQGTAIGQSDCHR-SRVKXCTJSA-N 0.000 description 1
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 1
- KHGPWGKPYHPOIK-QWRGUYRKSA-N Asp-Gly-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KHGPWGKPYHPOIK-QWRGUYRKSA-N 0.000 description 1
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 1
- NONWUQAWAANERO-BZSNNMDCSA-N Asp-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 NONWUQAWAANERO-BZSNNMDCSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 1
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- UWXFFVQPAMBETM-ZLUOBGJFSA-N Cys-Asp-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UWXFFVQPAMBETM-ZLUOBGJFSA-N 0.000 description 1
- ZGERHCJBLPQPGV-ACZMJKKPSA-N Cys-Ser-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N ZGERHCJBLPQPGV-ACZMJKKPSA-N 0.000 description 1
- 241000589601 Francisella Species 0.000 description 1
- MLZRSFQRBDNJON-GUBZILKMSA-N Gln-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N MLZRSFQRBDNJON-GUBZILKMSA-N 0.000 description 1
- NUMFTVCBONFQIQ-DRZSPHRISA-N Gln-Ala-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NUMFTVCBONFQIQ-DRZSPHRISA-N 0.000 description 1
- LLRJEFPKIIBGJP-DCAQKATOSA-N Gln-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N LLRJEFPKIIBGJP-DCAQKATOSA-N 0.000 description 1
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 1
- SXGMGNZEHFORAV-IUCAKERBSA-N Gln-Lys-Gly Chemical compound C(CCN)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N SXGMGNZEHFORAV-IUCAKERBSA-N 0.000 description 1
- VOUSELYGTNGEPB-NUMRIWBASA-N Gln-Thr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O VOUSELYGTNGEPB-NUMRIWBASA-N 0.000 description 1
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 1
- KBKGRMNVKPSQIF-XDTLVQLUSA-N Glu-Ala-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KBKGRMNVKPSQIF-XDTLVQLUSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- JGHNIWVNCAOVRO-DCAQKATOSA-N Glu-His-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JGHNIWVNCAOVRO-DCAQKATOSA-N 0.000 description 1
- NJPQBTJSYCKCNS-HVTMNAMFSA-N Glu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N NJPQBTJSYCKCNS-HVTMNAMFSA-N 0.000 description 1
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 1
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 1
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 1
- VXEFAWJTFAUDJK-AVGNSLFASA-N Glu-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O VXEFAWJTFAUDJK-AVGNSLFASA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- FFALDIDGPLUDKV-ZDLURKLDSA-N Gly-Thr-Ser Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O FFALDIDGPLUDKV-ZDLURKLDSA-N 0.000 description 1
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 1
- JBJNKUOMNZGQIM-PYJNHQTQSA-N His-Arg-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JBJNKUOMNZGQIM-PYJNHQTQSA-N 0.000 description 1
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 1
- NDKSHNQINMRKHT-PEXQALLHSA-N His-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N NDKSHNQINMRKHT-PEXQALLHSA-N 0.000 description 1
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 1
- ASCFJMSGKUIRDU-ZPFDUUQYSA-N Ile-Arg-Gln Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O ASCFJMSGKUIRDU-ZPFDUUQYSA-N 0.000 description 1
- UKTUOMWSJPXODT-GUDRVLHUSA-N Ile-Asn-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N UKTUOMWSJPXODT-GUDRVLHUSA-N 0.000 description 1
- QIHJTGSVGIPHIW-QSFUFRPTSA-N Ile-Asn-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N QIHJTGSVGIPHIW-QSFUFRPTSA-N 0.000 description 1
- PFTFEWHJSAXGED-ZKWXMUAHSA-N Ile-Cys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N PFTFEWHJSAXGED-ZKWXMUAHSA-N 0.000 description 1
- QRTVJGKXFSYJGW-KBIXCLLPSA-N Ile-Glu-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N QRTVJGKXFSYJGW-KBIXCLLPSA-N 0.000 description 1
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 1
- KBAPKNDWAGVGTH-IGISWZIWSA-N Ile-Ile-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KBAPKNDWAGVGTH-IGISWZIWSA-N 0.000 description 1
- FFJQAEYLAQMGDL-MGHWNKPDSA-N Ile-Lys-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FFJQAEYLAQMGDL-MGHWNKPDSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- UAELWXJFLZBKQS-WHOFXGATSA-N Ile-Phe-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O UAELWXJFLZBKQS-WHOFXGATSA-N 0.000 description 1
- IITVUURPOYGCTD-NAKRPEOUSA-N Ile-Pro-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IITVUURPOYGCTD-NAKRPEOUSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KEVYYIMVELOXCT-KBPBESRZSA-N Leu-Gly-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KEVYYIMVELOXCT-KBPBESRZSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 1
- IFMPDNRWZZEZSL-SRVKXCTJSA-N Leu-Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O IFMPDNRWZZEZSL-SRVKXCTJSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- AIRUUHAOKGVJAD-JYJNAYRXSA-N Leu-Phe-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIRUUHAOKGVJAD-JYJNAYRXSA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- LSLUTXRANSUGFY-XIRDDKMYSA-N Leu-Trp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O LSLUTXRANSUGFY-XIRDDKMYSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- HWMZUBUEOYAQSC-DCAQKATOSA-N Lys-Gln-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O HWMZUBUEOYAQSC-DCAQKATOSA-N 0.000 description 1
- DAOSYIZXRCOKII-SRVKXCTJSA-N Lys-His-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O DAOSYIZXRCOKII-SRVKXCTJSA-N 0.000 description 1
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- SKUOQDYMJFUMOE-ULQDDVLXSA-N Lys-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCCCN)N SKUOQDYMJFUMOE-ULQDDVLXSA-N 0.000 description 1
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 1
- RMOKGALPSPOYKE-KATARQTJSA-N Lys-Thr-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMOKGALPSPOYKE-KATARQTJSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZMYHJISLFYTQGK-FXQIFTODSA-N Met-Asp-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZMYHJISLFYTQGK-FXQIFTODSA-N 0.000 description 1
- VYXIKLFLGRTANT-HRCADAONSA-N Met-Tyr-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N VYXIKLFLGRTANT-HRCADAONSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 102100033223 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- NHCKESBLOMHIIE-IRXDYDNUSA-N Phe-Gly-Phe Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 NHCKESBLOMHIIE-IRXDYDNUSA-N 0.000 description 1
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 1
- RMKGXGPQIPLTFC-KKUMJFAQSA-N Phe-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RMKGXGPQIPLTFC-KKUMJFAQSA-N 0.000 description 1
- WEDZFLRYSIDIRX-IHRRRGAJSA-N Phe-Ser-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 WEDZFLRYSIDIRX-IHRRRGAJSA-N 0.000 description 1
- XDMMOISUAHXXFD-SRVKXCTJSA-N Phe-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O XDMMOISUAHXXFD-SRVKXCTJSA-N 0.000 description 1
- GKRCCTYAGQPMMP-IHRRRGAJSA-N Phe-Ser-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O GKRCCTYAGQPMMP-IHRRRGAJSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- WFIVLLFYUZZWOD-RHYQMDGZSA-N Pro-Lys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WFIVLLFYUZZWOD-RHYQMDGZSA-N 0.000 description 1
- QGLFRQCECIWXFA-RCWTZXSCSA-N Pro-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1)O QGLFRQCECIWXFA-RCWTZXSCSA-N 0.000 description 1
- XRGIDCGRSSWCKE-SRVKXCTJSA-N Pro-Val-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O XRGIDCGRSSWCKE-SRVKXCTJSA-N 0.000 description 1
- 102220576534 Regulatory solute carrier protein family 1 member 1_Q54L_mutation Human genes 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- OLIJLNWFEQEFDM-SRVKXCTJSA-N Ser-Asp-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLIJLNWFEQEFDM-SRVKXCTJSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 1
- XERQKTRGJIKTRB-CIUDSAMLSA-N Ser-His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CN=CN1 XERQKTRGJIKTRB-CIUDSAMLSA-N 0.000 description 1
- DOSZISJPMCYEHT-NAKRPEOUSA-N Ser-Ile-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O DOSZISJPMCYEHT-NAKRPEOUSA-N 0.000 description 1
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- DYEGLQRVMBWQLD-IXOXFDKPSA-N Ser-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CO)N)O DYEGLQRVMBWQLD-IXOXFDKPSA-N 0.000 description 1
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 1
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 1
- PAXANSWUSVPFNK-IUKAMOBKSA-N Thr-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N PAXANSWUSVPFNK-IUKAMOBKSA-N 0.000 description 1
- XTCNBOBTROGWMW-RWRJDSDZSA-N Thr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XTCNBOBTROGWMW-RWRJDSDZSA-N 0.000 description 1
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
- REJRKTOJTCPDPO-IRIUXVKKSA-N Thr-Tyr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O REJRKTOJTCPDPO-IRIUXVKKSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- AWEGFIJXYWGBCA-XIRDDKMYSA-N Trp-His-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AWEGFIJXYWGBCA-XIRDDKMYSA-N 0.000 description 1
- UKWSFUSPGPBJGU-VFAJRCTISA-N Trp-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O UKWSFUSPGPBJGU-VFAJRCTISA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- BGFCXQXETBDEHP-BZSNNMDCSA-N Tyr-Phe-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O BGFCXQXETBDEHP-BZSNNMDCSA-N 0.000 description 1
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 1
- CELJCNRXKZPTCX-XPUUQOCRSA-N Val-Gly-Ala Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O CELJCNRXKZPTCX-XPUUQOCRSA-N 0.000 description 1
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 1
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 1
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 108010045023 alanyl-prolyl-tyrosine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 108010021066 nicotinamide riboside kinase Proteins 0.000 description 1
- -1 nicotinamide-ribose nucleic acid Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010078580 tyrosylleucine Proteins 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1235—Diphosphotransferases (2.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/02—Pentosyltransferases (2.4.2)
- C12Y204/02011—Nicotinate phosphoribosyltransferase (2.4.2.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01015—Ribokinase (2.7.1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/06—Diphosphotransferases (2.7.6)
- C12Y207/06001—Ribose-phosphate diphosphokinase (2.7.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
- C12Y603/01005—NAD+ synthase (6.3.1.5)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明属于生物工程技术领域，具体涉及一种重组大肠杆菌生物合成NMN的方法。所述工程菌是在大肠杆菌宿主中，通过缺失对烟酰胺核苷酸酰胺酶编码基因pncC、烟酰胺单核苷酸腺苷转移酶基因nadD、nadR的表达的同时，过表达NAD+合酶编码基因nadE；表达烟酸磷酸核糖转移酶突变体编码基因NadVmu、核糖磷酸二磷酸激酶编码基因Prs以及核糖激酶编码基因RbsK获得的；本发明同时对NadV进行了定向进化，使催化效率达到最佳。本发明采用上述重组菌全细胞为催化剂催化转化，方法简单；反应底物为烟酰胺和核糖，生产成本较低；建了依赖烟酰胺和核糖的NMN生物合成途径，使相关酶能够高效表达，使NMN产量达到2.88g/L。
Description
技术领域：
本发明属于生物工程技术领域，具体涉及一种重组大肠杆菌生物合成NMN的方法。
背景技术：
作为生命体内200多种还原反应的辅酶，NAD是3类NAD消耗酶的底物，在多种细胞的生理过程中起着至关重要的作用，NAD的生物能量状态甚至决定了细胞的生死存亡。同时，NAD的代谢在健康和疾病状态中起着重要作用，逐渐引起人们的关注，因此参与NAD生物合成和代谢的酶也成为了疾病治疗中具有关注热度的药物靶标。
NMN(nicotinamide mononucleotide)，即烟酰胺单核苷酸，是一种自然存在的生物活性核苷酸，NMN作为细胞内参与NAD合成的重要底物，在人体细胞能量生成中扮演重要角色。NMN是人体内原本存在的物质，但随着年龄的增长而减少。在哺乳动物体内，NMN主要由烟酰胺在烟酰胺磷酸核糖转移酶(Nicotinamide phosphate ribose transferase，Nampt)的催化作用下生成，随后NMN在烟酰胺单核苷酸腺苷转移酶的催化下生成NAD+。在细胞外的NMN则需要脱去磷酸转化为烟酰胺核糖(NR)才能进入肝细胞内部，进入胞内后，烟酰胺核糖在烟酰胺核苷激酶的作用下再磷酸化生成NMN，随后NMN和ATP结合生成NAD+。
目前NMN合成主要通过化学催化与酶催化进行。传统的体外制备β-烟酰胺单核苷酸的方法为化学合成法，催化NMN时需要用到危险化学品和大量的有机溶剂，会破坏环境且操作复杂、反应步骤多、中间产物多、得率低、产品纯化困难。比如，Tanimori等人用乙酰基保护的核糖与烟酰胺在TMSOTf的催化下发生缩合反应；又比如Palmarisa等人使用硅烷化试剂对烟酰胺进行硅烷化，然后与乙酰核糖在TMSOTf的催化下进行反应。这些化学合成方法存在成本高、收率低而且化学试剂污染大等问题。
至于酶催化，所需原料ATP比较昂贵，生产NMN的成本很高。早在1994年，Jeck等利用二磷酸吡啶核苷酸为原料，在焦磷酸化酶的催化水解下生成烟酰胺单核苷酸。2016年，深圳邦泰公司利用烟酰胺、ATP和核糖为底物，在烟酰胺磷酸核糖转移酶、核糖磷酸焦磷酸激酶以及核糖激酶的催化下生成烟酰胺单核苷酸。2017年，该公司进一步改进工艺，以烟酰胺、焦磷酸或其盐和AMP为原料，在烟酰胺磷酸核糖转移酶和腺膘呤磷酸核糖转移酶的催化作用下发生反应，获得烟酰胺单核苷酸；该工艺优势在于使用磷酸核糖焦磷酸为原料，降低了成本。2018年，尚科生物报道以D-5-磷酸核糖、ATP和烟酰胺为原料，通过固定化含有磷酸核糖焦磷酸合成酶和烟酰胺磷酸核糖转移酶的活性细胞，实现了高效生物催化合成β-烟酰胺单核苷酸。固定化细胞或固定化酶可以重复多次使用，利于纯化，以降低生产成本，但是合成所需原料ATP相对比较昂贵，也增加了NMN的生产成本。
因此考虑到食品安全因素以及化学催化与酶催化的环境污染问题和局限性，目前多使用生物合成法制备NMN，即通过构建工程菌使相关酶在大肠杆菌中重组表达，再进行发酵生产。最早由Marinescu等构建基因工程菌发酵合成NMN，该团队将烟酰胺磷酸核糖转移酶和5’-磷酸核糖焦磷酸(Phosphoribosyl_pyrophosphate，PRPP)合成酶在大肠杆菌中重组表达，以尼克酰胺和乳糖为底物进行发酵生产，但最终NMN产量比较低，仅为15.4mg/L。随后该团队还开发了分子筛色谱法分离NMN的方法，但是从色谱图发现，还是有大量尼克酰胺没有转化为NMN。分析可知，NMN合成涉及细胞能量代谢，未来可以通过高密度发酵提高单位体积的产物得率。生物合成的NMN产量比较低，且合成出NMN后有较多的途径分解NMN，最终导致NMN在微生物体内无法保存较高的含量，因此常规的生物合成手段无法解决高效发酵生产NMN的问题。
发明内容：
为了解决上述技术问题，本发明通过降低或敲除了大肠杆菌菌体内降解NMN的功能基因，使产生的NMN不容易被降解。利用基因编辑技术对这些途径的基因进行敲除，并通过启动子温敏突变体的替换从而构建出了一株可以在菌体内高效保留NMN的工程菌株。另外本发明在该菌株中构建了一条依赖于烟酰胺、核糖的NMN的生物合成途径。然后通过易错PCR筛选技术，筛选出了一个NadV的突变体，该突变体可以在该菌株体系中更高效的生成NMN。
本发明提供的技术方案之一，是一株可以大量合成并积累NMN(nicotinamidemononucleotide，即烟酰胺单核苷酸)的大肠杆菌基因工程菌，所述工程菌是在大肠杆菌宿主中，缺失对烟酰胺核苷酸酰胺酶编码基因pncC、烟酰胺单核苷酸腺苷转移酶基因nadD、nadR的表达的同时，过表达NAD+合酶编码基因nadE来提高NMN的保留量；表达烟酸磷酸核糖转移酶突变体编码基因NadVmu、核糖磷酸二磷酸激酶编码基因Prs以及核糖激酶编码基因RbsK来构建依赖烟酰胺和核糖的NMN生物合成途径；
进一步地，pncC、nadR基因缺失表达的方式为基因敲除；
进一步地，nadD基因缺失表达的方式为通过CIts蛋白及PR/PL启动子温敏控制nadD基因的表达；
进一步地，nadE基因通过pET-28a载体进行表达；
进一步地，NadVmu、Prs、RbsK基因通过质粒过表达；
优选地，采用pGEX4T3载体对NadVmu、Prs、RbsK基因进行过表达；
进一步地，野生型NadV基因的核苷酸序列如序列表SEQ ID NO：1所示；
进一步地，pncC基因的核苷酸序列如序列表SEQ ID NO：2所示；
进一步地，nadD基因的核苷酸序列如序列表SEQ ID NO：3所示；
进一步地，nadR基因的核苷酸序列如序列表SEQ ID NO：4所示；
进一步地，nadE基因的核苷酸序列如序列表SEQ ID NO：5所示；
进一步地，Prs基因的核苷酸序列如序列表SEQ ID NO：6所示；
进一步地，RbsK基因的核苷酸序列如序列表SEQ ID NO：7所示；
进一步地，烟酸磷酸核糖转移酶突变体编码基因NadVmu的核苷酸序列如序列表SEQID NO：11所示；烟酸磷酸核糖转移酶突变体的氨基酸序列如SEQ ID NO：12所示；
进一步地，所述大肠杆菌宿主选自JM109、BL21(DE3)、Top 10、DH5α、Rosetta、Rosetta-gami pLysS等；
优选地，所述大肠杆菌宿主为大肠杆菌JM109。
本发明提供的技术方案之二，是上述基因工程菌的构建方法，具体如下：
(1)构建高NMN保留量的工程菌株
利用大肠杆菌基因编辑载体pCas9对大肠杆菌宿主细胞基因组进行基因编辑，构建pncC、nadR基因的敲除菌株(JM109ΔpncCΔnadR)，因nadD途径无法敲除，所以通过ts温敏表达对nadD的表达进行控制，构建温敏表达nadD的工程菌株(JM109ΔpncCΔnadR nadD(ts))；继续在基因组构建受到IPTG诱导的nadE基因；该菌株作为底盘细胞可以高效的保存大肠杆菌合成的NMN不被降解；
(2)构建依赖烟酰胺和核糖的NMN生物合成途径
利用pGEX4T3载体为骨架，构建可在IPTG诱导情况下高效表达NadVmu、Prs以及RbsK的表达载体，并将所述表达载体在步骤(1)所得菌株中表达。
本发明提供的技术方案之三，是上述工程菌在生产NMN中的应用；
进一步地，采用上述工程菌发酵生产NMN的方法如下：
反应体系包括：烟酰胺5-20mmol/L、核糖10-20mmol/L、ATP 5-10mmol/L、NAD+ 5-10mmol/L、Na2HPO4/NaH2PO4 50mmol/L、醋酸钠10mmol/L、氯化钙1mmol/L，其余为水pH5-8.5；加入生产菌使菌体浓度达到5-100g/L，在15-22℃，50-200rpm，避光下反应10-25h；
10-25h后，NMN产量达到1.31-2.88g/L；
进一步地，菌体培养方法如下：
将工程菌种子液按1％的接种量接种于PYA8培养基中，37℃、200rpm培养6h(OD600为0.7左右)，自来水冷却10min，加1mM IPTG后，22℃、200rpm条件下诱导表达24h；离心收集菌体；
更进一步地，所述PYA8培养基组成为(w/v)：0.1％大豆蛋白胨，1％葡萄糖，1.61％磷酸氢二钠，0.136％磷酸二氢钾，0.05％氯化钠，0.5％酵母浸膏，1％醋酸钠，其余为水，pH7.0～7.2；
优选地，NMN生物转化条件为：菌体浓度为50g/L，烟酰胺15mmol/L、核糖20mmol/L、ATP 5mmol/L、NAD+ 10mmol/L，pH8.0，20℃，100rpm，避光下反应20h；NMN产量达到8.36mmol/L。
有益效果：
与现有技术相比，本发明具有以下优点：
1、本发明采用特定的重组大肠杆菌全细胞为催化剂催化转化，方法简单；反应底物为烟酰胺和核糖，生产成本较低；本发明构建了依赖烟酰胺和核糖的NMN生物合成途径，使相关酶能够高效表达，提高了NMN产量。
2、采用本发明方法进行生物转化，敲除了大肠杆菌菌体内降解NMN的功能基因，使产生的NMN不容易被降解，高效保留NMN，提高了产量，NMN产量达到2.88g/L。
3、本发明对NadV即编码合成烟酸磷酸核糖转移酶的基因进行了定向进化，使该酶的催化效率达到最佳，可将NMN产量由1.88g/L提高到2.88g/L。
附图说明：
图1基因编辑载体pCas9质粒图谱；
图2 pTargetF质粒图谱；
图3 pncC基因敲除验证；
图4 nadR基因敲除验证；
图5温敏表达nadD基因验证；
图6 pGEX4T3-NadV-Prs-RbsK质粒图谱。
具体实施方式：
为了使本专利的目的、技术方案及优点更加清楚明白，以下结合具体实施例，对本专利进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本专利，并不用于限定本发明。
实施例1 NMN生产基因工程菌株的构建
(1)构建高NMN保留量的工程菌株
利用大肠杆菌基因编辑载体pCas9对大肠杆菌宿主细胞JM109基因组进行基因编辑，构建pncC、nadR基因的敲除菌株(JM109ΔpncCΔnadR)，因nadD途径无法敲除，所以再构建温敏表达nadD的工程菌株(JM109ΔpncCΔnadR nadD(ts))；继续在基因组构建受到IPTG诱导的nadE基因；该菌株作为底盘细胞可以高效的保存大肠杆菌合成的NMN不被降解；
具体的构建步骤如下：
①底盘构建
如附图1所示，将大肠杆菌基因编辑载体pCas9转化入JM109感受态细胞，获得稳定表达CAS9蛋白的底盘。
②pncC基因进行敲除
采用pTargetF为载体，在其中插入sgRNA序列1和供体DNA片段，得到重组质粒，将重组质粒转化至表达CAS9蛋白的JM109感受态细胞，得到包含质粒的敲除菌株，经筛选得到敲除菌株JM109ΔpncC。
其中，pncC的核苷酸序列如SEQ ID NO.2所示，蛋白ID：AAN81705.1，通过NCBI数据库获取得到。pTargetF质粒如图2所示。
首先，利用CRISPR网站(http://crispr.dbcls.jp/)进行分析，选取评分较高且靠近起始密码子的序列为基因敲除靶点，设计靶点序列引物，通过PCR方式将敲除靶点序列引入至pTargetF质粒上的启动子和gRNA scaffold序列之间，使靶点序列和gRNA scaffold序列连接形成sgRNA序列1，获得pTargetF-1质粒。进一步根据pncC上下游各300bp左右的序列设计pncC上、下游同源臂引物，分别引入Xho I和PshA I酶切位点。通过PCR获得上下游同源臂，再用F3和R2引物，通过融合PCR方式获得供体DNA片段，序列如SEQ ID NO.8所示。
然后将pTargetF-1质粒和供体DNA进行双酶切，回收片段之后连接，转化步骤①获得的表达CAS9蛋白的JM109感受态细胞，再涂布氯霉素/壮观霉素双抗平板，以筛选引物对长出的单克隆进行菌落PCR检测，结果如图3所示(原长度1312bp(阴性)，敲除部分472bp，成功敲除后840bp(阳性))，筛选出成功敲除pncC的阳性克隆，再用氯霉素单抗性培养基进行连续传代培养，得到去除pTargetF质粒的JM109ΔpncC菌株。
相关引物或序列见表1记载：
表1.pncC基因敲除相关序列
③nadR基因敲除
采用pTargetF为载体，在其中插入sgRNA序列2和供体DNA片段，得到重组质粒，将重组质粒转化至JM109ΔpncC感受态细胞，得到包含质粒的敲除菌株，经筛选得到敲除菌株JM109ΔpncCΔnadR。
其中，nadR的核苷酸序列如SEQ ID NO.4所示，蛋白ID：ACI72736.1，通过NCBI数据库获取得到。
与步骤②相同，同样的选择基因敲除靶点，设计引物将靶点序列插入pTargetF载体，形成sgRNA序列2，获得pTargetF-2质粒。设计nadR基因上、下游同源臂引物，引入Xho I和PshA I酶切位点，获取两段同源臂后，通过融合PCR获得供体DNA片段，序列如SEQ IDNO.9所示。然后将pTargetF-2质粒和供体DNA进行双酶切，回收片段之后连接，转化步骤②获得的JM109ΔpncC的感受态细胞，再涂布氯霉素/壮观霉素双抗平板。以筛选引物对长出的单克隆进行菌落PCR检测，结果如图4所示(原长度1723bp(阴性)，敲除部分1098bp，成功敲除后625bp(阳性))，筛选出成功敲除nadR的阳性单克隆，再用氯霉素单抗性培养基进行连续传代培养，得到去除pTargetF质粒的JM109ΔpncCΔnadR菌株。
相关引物或序列见表2记载：
表2.nadR基因敲除相关序列
④温敏表达nadD基因的菌株构建
采用pTargetF为载体，在其中插入sgRNA序列3和供体DNA片段，得到重组质粒，将重组质粒转化至JM109ΔpncCΔnadR感受态细胞，经筛选得到菌株JM109ΔpncCΔnadRnadD(ts)。
nadD的核苷酸序列如SEQ ID NO.3所示，蛋白ID：CTV94997.1，来源于E.coli。
根据nadD上游区域序列分析基因插入靶点，设计引物将靶点序列插入pTargetF载体，形成sgRNA序列3，获得pTargetF-3质粒。选择nadD基因的上游部分序列和基因前段部分序列为两段同源臂，中间插入CIts蛋白及PR/PL启动子序列(SEQ ID NO.10)，两端引入XhoI和PshAI酶切位点，共约2.2kb进行全合成，得到供体DNA片段。
将pTargetF-3质粒和供体DNA进行双酶切，回收片段之后连接，转化步骤③获得的JM109ΔpncCΔnadR感受态细胞，再涂布氯霉素/壮观霉素双抗平板。以筛选引物对长出的单克隆进行菌落PCR，结果如图5所示(成功插入DNA的单克隆可以通过PCR检测到1kb左右的条带(阳性)，未成功插入的无法检测到条带(阴性))，筛选出改造成功的阳性单克隆，再用氯霉素单抗性培养基进行连续传代培养，得到去除pTargetF质粒的JM109ΔpncCΔnadRnadD(ts)，使nadD成为温敏表达型蛋白。
相关引物或序列见表3记载：
表3.温敏表达nadD基因的菌株构建相关序列
⑤IPTG诱导nadE基因的菌株构建
nadE的核苷酸序列如SEQ ID NO.5所示，蛋白ID：WP_003037081.1，来源于弗朗西斯氏菌(Francisella tularensis)。
全合成nadE基因序列，5’端引入EcoR I酶切位点，3’端引入Nco I酶切位点，即：5’-CCGGAATTC-nadE-CCATGGATG-3’，共765bp。用pET-28a载体构建重组质粒，基因片段和pET-28a质粒均进行Nco I/EcoR I双酶切，回收酶切片段，用T4连接酶进行连接。转化入步骤④获得的JM109ΔpncCΔnadR nadD(ts)感受态细胞，在含有Kan+的LB平板上涂布，挑取转化子进行验证，得到JM109ΔpncCΔnadR nadD(ts)-nadE菌株。
(2)构建依赖烟酰胺和核糖的NMN生物合成途径
利用pGEX-4T-3载体为骨架以及tac启动子控制元件，构建可在IPTG诱导情况下高效表达NadV、Prs以及RbsK的表达载体，并将所述表达载体在步骤(1)所得菌株中表达。
用pGEX-4T-3载体构建重组质粒，分别从NCBI数据库获取NadV、Prs以及RbsK的CDS序列(SEQ ID NO.1、6、7)，中间插入lac操纵子及tac启动子元件，两端分别设计BamHII和NotI酶切位点，共3330bp的序列进行全合成。然后将合成序列与pGEX-4T-3质粒分别进行双酶切，回收酶切片段，进行连接，构建pGEX4T3-NadV-Prs-RbsK质粒，如图6所示。将连接产物转化入JM109ΔpncCΔnadR nadD(ts)-nadE感受态细胞，在含有Kan+和Amp+双抗的LB平板上涂布，挑取转化子进行验证，获得重组菌JM109ΔpncCΔnadR nadD(ts)-nadE，pGEX4T3-NadV-Prs-RbsK。
实施例2 NadV定向进化
NadV(烟酸磷酸核糖转移酶)是决定NMN合成的关键基因，该基因的催化效率以及催化的最适环境是配合其它两个酶(核糖磷酸二磷酸激酶编码基因Prs以及核糖激酶编码基因RbsK)催化的关键因素，而野生型NadV的催化效率达不到配适需求。
本发明利用易错PCR技术对NadV进行了进化筛选，选取在LB培养基中生长速度下降的菌株为筛选目标。
具体为：以实施例1构建的pGEX4T3-NadV-Prs-RbsK质粒为模板，设计NadV两端的引物，分别引入BamHI和SgrAI酶切位点，用易错PCR方式进行突变。将PCR产物和模板质粒进行BamHI/SgrAI双酶切，回收片段进行连接，再转化JM109ΔpncCΔnadR nadD(ts)-nadE感受态细胞。
以在LB培养基中生长速度下降的菌株为筛选目标，筛选出菌株后，接种在96孔板的LB培养基中，37℃震荡培养4h，降温至22℃,加入IPTG诱导表达24h，得到菌液；然后在96孔板中加入反应体系进行反应，所述反应体系为4mM NR(烟酰胺核糖)，2mM ATP，2mM氯化钙，与菌液按体积比1:1混合，20℃反应1h，离心得到上清液。
取上清液，用荧光酶标仪进行荧光检测(入射光382nm，发射光445nm)，荧光越强表明产NMN能力越强，最终筛选出6株荧光较强的突变体，对这些菌株测序发现其有2个共同的突变位点：Q54L和D453G。
以pGEX4T3-NadV-Prs-RbsK质粒为模板，设计引物在这两处进行定点突变，将突变后的质粒转化回JM109ΔpncCΔnadR nadD(ts)-nadE感受态细胞，挑选单克隆验证，经测序后确认构建出工程菌JM109ΔpncCΔnadR nadD(ts)-nadE，pGEX4T3-NadVmu-Prs-RbsK。
点突变引物：
点突变后获得的烟酸磷酸核糖转移酶突变体编码基因NadVmu的核苷酸序列如序列表SEQ ID NO：11所示，烟酸磷酸核糖转移酶突变体氨基酸序列如SEQ ID NO：12所示。
实施例3NMN生物合成
(1)菌株培养及表达。
实验菌株：
实施例2构建的重组菌JM109ΔpncCΔnadR nadD(ts)-nadE，pGEX-NadVmu-Prs-RbsK；
实施例1构建的重组菌JM109ΔpncCΔnadR nadD(ts)-nadE，pGEX-NadV-Prs-RbsK。
挑取重组大肠杆菌接种于20mL含卡那霉素50μg/mL、氨苄100μg/mL的LB培养，37℃、200rpm培养16h，然后按1％接种于PYA8培养基(0.1％大豆蛋白胨，1％葡萄糖，1.61％磷酸氢二钠；0.136％磷酸二氢钾；0.05％氯化钠；0.5％酵母浸膏；1％醋酸钠，其余为水，pH7.0～7.2)培养基中(500ml三角瓶)，37℃、200rpm培养6h(OD600(～0.7))，自来水冷却10min，加1mM IPTG后，22℃、200rpm条件下诱导表达24h。然后离心(4℃，10000g，离心5min)收集菌体。
(2)NMN生物转化
使用上述收集菌体为催化剂进行生物转化，按表1称取原料配置反应液，溶解后加入菌体，搅拌均匀，在对应条件下避光反应得到产物。
(3)产物测定
反应结束后，向反应液中加入1/2倍体积的双蒸水，置10℃，10min。在4℃、12000g条件下离心10min，收集上清，在向上清中加入5倍体积的丙酮，置4℃过夜，在4℃、12000g条件下离心10min，收集沉淀，得到初步纯化的反应物。再采用去离子水溶解沉淀，对反应产物进行高效液相色谱法(HPLC法)。
色谱条件如下：
检测前样品处理——用70％甲醇水溶液将样品稀释50倍，然后用孔径为0.22μm的微孔滤器过滤后装到样品瓶中；
仪器设备——美国安捷伦公司1260高效液相色谱仪；
色谱柱：Phenomenex Luna C18色谱柱(4.6mm×250mm 5μm)；
柱温：35℃；
流动相：流动相为流动相A为0.25％磷酸二氢钠和0.2‰磷酸的水溶液；流动相B为甲醇，流动相A：流动相B＝1：1；
进样量：5μL。
流速：0.3mL/min。
表1 重组大肠杆菌催化体系
上述结果说明，由本发明构建的重组菌JM109ΔpncCΔnadR nadD(ts)-nadE，pGEX-NadVmu-Prs-RbsK，生产NMN的产量能够达到8.26mmol/L(约为2.88g/L)，且经过改造后的烟酸磷酸核糖转移酶突变体能够进一步提高NMN的产量。
以上所述实施例仅表达了本发明的几种实施方式，其描述较为具体和详细，但并不能因此而理解为对专利范围的限制。应当指出的是，对于本领域的普通技术人员来说，在不脱离本专利构思的前提下，上述各实施方式还可以做出若干变形、组合和改进，这些都属于本专利的保护范围。因此，本专利的保护范围应以权利要求为准。
SEQUENCE LISTING
<110> 四川盈嘉合生科技有限公司
<120> 一种生物合成NMN的方法
<130> 1
<160> 12
<170> PatentIn version 3.5
<210> 1
<211> 1488
<212> DNA
<213> 湿热淋病杆菌（Haemophilusducreyi）
<400> 1
atggacaacc tgctgaacta tagcagccgt gcgagcgcga tcccgagcct gctgtgcgat 60
ttctacaaga ccagccaccg tattatgtat ccggagtgca gccagatcat ttacagcacc 120
tttaccccgc gtagcaacga acaggcgccg tacctgaccc aagtggttag cttcggtttt 180
caagcgttca tcatcaagta cctgatccac tacttcaacg acaacttctt tagccgtgac 240
aagcacgatg tggttaccga gtatagcgcg ttcatcgaaa aaaccctgca actggaggat 300
accggtgaac acattgcgaa gctgcacgag ctgggctacc tgccgatccg tattaaagcg 360
atcccggaag gcaagaccgt ggcgatcaaa gtgccggtta tgaccattga gaacacccac 420
agcgacttct tttggctgac caactatctg gaaaccctga ttaacgttag cctgtggcaa 480
ccgatgacca gcgcgagcat cgcgttcgcg taccgtaccg cgctgattaa gtttgcgaac 540
gagacctgcg acaaccagga acacgtgccg ttccaaagcc acgattttag catgcgtggt 600
atgagcagcc tggagagcgc ggaaaccagc ggtgcgggtc acctgaccag cttcctgggc 660
accgacacca tcccggcgct gagctttgtt gaggcgtact atggtagcag cagcctgatc 720
ggcaccagca ttccggcgag cgagcacagc gtgatgagca gccacggtgt tgatgaactg 780
agcaccttcc gttatctgat ggcgaagttt ccgcacaaca tgctgagcat cgtgagcgac 840
accaccgatt tctggcacaa cattaccgtt aacctgccgc tgctgaaaca ggagatcatt 900
gcgcgtccgg aaaacgcgcg tctggtgatc cgtccggaca gcggtaactt ctttgcgatc 960
atttgcggcg acccgaccgc ggataccgag cacgagcgta agggtctgat cgaatgcctg 1020
tgggacattt tcggtggcac cgtgaaccag aagggttata aagttattaa cccgcacatc 1080
ggcgcgattt acggtgatgg cgttacctat gagaagatgt ttaaaatcct ggaaggtctg 1140
caagcgaaag gcttcgcgag cagcaacatt gtgtttggtg ttggcgcgca gacctaccaa 1200
cgtaacaccc gtgacaccct gggtttcgcg ctgaaggcga ccagcatcac cattaacggc 1260
gaggaaaaag cgatcttcaa gaacccgaaa accgacgatg gttttaagaa aagccagaag 1320
ggccgtgtga aagttctgag ccgtgacacc tacgtggatg gtctgaccag cgcggacgat 1380
ttcagcgacg atctgctgga gctgctgttt gaagatggca aactgctgcg tcagaccgac 1440
tttgatgaga tccgtcaaaa cctgctggtt agccgtacca ccctgtaa 1488
<210> 2
<211> 498
<212> DNA
<213> 大肠杆菌(Escherichia coli)
<400> 2
atgactgaca gtgaactgat gcagttaagt gaacaggttg ggcaggcgct gaaagcccgt 60
ggcgcaaccg taacaactgc cgagtcttgt accggtggtt gggtagcgaa agtgattacc 120
gatattgccg gtagctccgc ctggtttgaa cgcggatttg tcacctacag taacgaagcc 180
aaagcgcaga tgatcggcgt acgcgaagag acgctggcgc agcatggcgc ggtgagtgaa 240
cccgtcgtgg tggaaatggc gataggcgca ctgaaagcgg ctcgtgctga ttatgccgtg 300
tctattagtg gtatcgccgg gccggatggc ggcagtgaag agaagcctgt cggcaccgtc 360
tggtttgctt ttgccactgc ccgcggtgaa ggcattaccc ggcgggaatg cttcagcggc 420
gaccgtgatg cggtgcgtcg tcaggctact gcgtatgcat tgcagacctt gtggcaacaa 480
tttctacaaa acacttga 498
<210> 3
<211> 642
<212> DNA
<213> 大肠杆菌(Escherichia coli)
<400> 3
atgaaatctt tacaggctct gtttggcggc acctttgatc cggtgcacta tggtcatcta 60
aaacccgtgg aaacgctggc gaatttgatt ggtctgacgc gggtcacaat catccctaat 120
aatgttcctc cgcatcgtcc ccagccggaa gcgaacagcg tgcagcgtaa acacatgctt 180
gaactggcga ttgccgacaa gccattattt actcttgatg aacgcgagct aaagcgcaat 240
gccccctctt acactgcgca aacactgaaa gagtggcggc aggaacaagg accggacgtg 300
ccgctggcgt ttattattgg tcaggattca ctgctgacct ttccgacctg gtacgaatac 360
gaaacgatac tcgacaatgc acatttgatc gtctgtcggc gtccaggtta cccacttgaa 420
atggcgcaac cgcaatacca gcaatggctg gaagatcatt tgacacataa cccggaagat 480
cttcaccttc agcctgccgg taaaatttat ctggctgaaa cgccgtggtt taacatctcg 540
gcgaccatca tccgcgaacg tttgcaaaac ggtgaatcat gtgaggattt attgccggaa 600
ccggtactga cttacattaa ccaacaaggc ttgtatcgct ga 642
<210> 4
<211> 1233
<212> DNA
<213> 大肠杆菌(Escherichia coli)
<400> 4
atgtcgtcat ttgattacct gaaaactgcc atcaagcaac agggctgcac gctacagcag 60
gtagctgatg ccagcggtat gaccaaaggg tatttaagcc agttactgaa tgccaaaatc 120
aaaagcccca gcgcgcaaaa gctggaggcg ttgcaccgtt ttttggggct tgagtttccc 180
cggcagaaga aaacgatcgg tgtcgtattc ggtaagttct acccactgca taccggacat 240
atctacctta tccagcgcgc ctgtagccag gttgacgagc tgcatatcat tatgggtttt 300
gacgataccc gtgaccgcgc gttgttcgaa gacagtgcca tgtcgcagca gccgaccgtg 360
ccggatcgtc tgcgttggtt attgcaaact tttaaatatc agaaaaatat tcgcattcat 420
gctttcaacg aagagggcat ggagccgtat ccgcacggct gggatgtgtg gagcaacggc 480
atcaaaaagt ttatggctga aaaagggatc cagccggatc tgatctacac ctcggaagaa 540
gccgatgcgc cacagtatat ggaacatctg gggatcgaga cggtgctggt cgatccgaaa 600
cgtaccttta tgagtatcag cggtgcgcag atccgcgaaa acccgttccg ctactgggaa 660
tatattccta ccgaagtgaa gccgtttttt gtgcgtaccg tggcgatcct tggcggcgag 720
tcgagcggta aatccaccct ggtaaacaaa cttgccaata tcttcaacac caccagtgcg 780
tgggaatatg gccgcgatta tgtcttttca cacctcggcg gtgatgagat cgcattgcag 840
tattctgact acgataaaat cgcgctgggc cacgctcaat acattgattt tgcggtgaaa 900
tatgccaata aagtggcatt tatcgatacc gattttgtca ccactcaggc gttctgcaaa 960
aagtacgaag ggcgggaaca tccgttcgtg caggcgctga ttgatgaata ccgtttcgat 1020
ctggtgatcc tgctggagaa caacacgccg tgggtggcgg atggtttacg cagcctcggc 1080
agttcggtgg atcgcaaaga gttccagaac ttgctggtgg agatgctcga agagaacaat 1140
atcgaatttg tgcgggttga agaggaagat tacgacagtc gtttcctgcg ctgcgtggaa 1200
ctggtgcggg agatgatggg ggagcagaga taa 1233
<210> 5
<211> 750
<212> DNA
<213> 土拉热弗朗西斯杆菌（Francisellatularensis）
<400> 5
atgaagattg tgaaagattt cagcccgaaa gaatacagcc agaaactggt gaactggctg 60
agcgatagct gcatgaacta tccggcggaa ggctttgtga ttggcctgag cggcggcatt 120
gatagcgcgg tggcggcgtc attagcggtg aaaaccggtt taccgaccac cgcgctgatt 180
ctgccgagcg ataataacca gcatcaggat atgcaggatg cgctggatct gattgaaatg 240
ctgaacattg aacattacac catcagcatt cagccggcgt atgaagcgtt tctggcgagc 300
acccagcgct ttaccaacct gcagaacaac cgccagctgg tgattaaagg caacgcgcag 360
gcgcgtctgc gcatgatgta tctgtatgcg tatgcgcagc agtataaccg cattgtgatt 420
ggcaccgata acgcgtgcga atggtatatg ggctatttta ccaaatttgg cgatggcgcg 480
gcggatattc tgccgctggt taacttgaag aaaagccagg tgtttgagct gggcaaatat 540
ctggatgtgc cgaaaaacat tctggataaa gcgccgagcg cgggcctgtg gcaaggtcag 600
accgatgaag atgaaatggg cgtgacctat caggaaattg atgattttct ggatggcaaa 660
caggtgagcg cgaaagcgct ggaacgcatt aacttttggc ataaccgcag ccatcataaa 720
cgcaaactgg cgctgacccc gaacttttaa 750
<210> 6
<211> 954
<212> DNA
<213> 人工序列
<400> 6
atgagcaacg agtacggcga caagaacctg aaaattttca gcctgaacag caacccggag 60
ctggcgaagg aaatcgcgga taacgtgggt gttcagctgg gcaaatgcag cgtgacccgt 120
tttagcgacg gcgaagttca aatcaacatt gaggaaagca tccgtggttg cgattgctac 180
atcattcaga gcaccagcgc gccggtgaac gagcacatta tggaactgct gatcatggtt 240
gacgcgctga agcgtgcgag cgcgaaaacc atcaacattg tgatcccgta ctatggttat 300
gcgcgtcaag atcgtaaggc gcgtagccgt gagccgatca ccgcgaaact gtttgcgagc 360
ctgctggaaa ccgcgggcgc gacccgtgtg attgcgctgg acatccacgc gccgcagatt 420
caaggtttct ttgacattcc gatcgatcac ctgatgggtg ttccgatcct gggccactat 480
tttgagggca aggacctgaa agatattgtg atcgttagcc cggatcatgg tggcgttacc 540
cgtgcgcgta agctggcgga ccgtctgaaa gcgccgattg cgatcattga taagcgtcgt 600
ccgcgtccga acgaggtgga agttatgaac atcgtgggta acgttgaagg caaaaccgcg 660
attctgatcg acgacatcat tgataccgcg ggcaccatca ccctggcggc gaacgcgctg 720
gttgagaacg gtgcggcgga agtttacgcg tgctgcaccc acccggtgct gagcggtccg 780
gcggttgagc gtattaacaa cagcaagatc aaagaactgg tggttaccaa cagcattaag 840
ctgccggagg aaaagaaaat cgagcgtttc aaacaactga gcgtgggtcc gctgctggcg 900
gaggcgatca ttcgtgtgca cgaaaagcaa agcgttagct acctgttcag ctaa 954
<210> 7
<211> 930
<212> DNA
<213> 大肠杆菌(Escherichia coli)
<400> 7
atgcaaaacg caggcagcct cgttgttctt ggcagcatta atgctgacca cattcttaat 60
cttcaatctt ttcctactcc aggcgaaacc gtaaccggta accactatca ggttgcattt 120
ggcggcaaag gcgcgaatca ggctgtggct gctgggcgta gcggtgcgaa tatcgcgttt 180
attgcctgta cgggtgatga cagcattggt gagagcgttc gccagcagct cgccactgat 240
aacattgata ttactccggt cagcgtgatc aaaggcgaat caacaggtgt ggcgctgatt 300
tttgttaatg gcgaaggtga gaatgtcatc ggtattcatg ccggcgctaa tgctgccctt 360
tccccggcgc tggtggaagc gcaacgtgag cgtattgcca acgcgtcagc attattaatg 420
cagctggaat caccactcga aagtgtgatg gcagcggcga aaatcgccca tcaaaataag 480
actatcgttg cgcttaaccc ggctccggct cgcgaacttc ctgacgaact gctggcgctg 540
gtggacatta ttacgccaaa cgaaacggaa gcagaaaagc tcaccggtat tcgtgttgaa 600
aatgatgaag atgcagcgaa ggcggcgcag gtactgcatg aaaaaggtat ccgtactgta 660
ctgattactt taggaagtcg tggtgtatgg gctagcgtga atggtgaagg tcagcgcgtt 720
cctggattcc gggtgcaggc tgtcgatacc attgctgccg gagatacctt taacggtgcg 780
ttaatcacgg cattgctgga agaaaaacca ttgccagagg cgattcgttt tgcccatgct 840
gccgctgcga ttgccgtaac acgtaaaggc gcacaacctt ccgtaccgtg gcgtgaagag 900
atcgacgcat ttttagacag gcagaggtga 930
<210> 8
<211> 726
<212> DNA
<213> 人工序列
<400> 8
ctactcgaga acgccacagc agccgctggg caaccatcaa caagccagcc tgctgcgtct 60
ggatgttggc accggctacc agtactggta cggtctgccg aacttctaca ccatcacccg 120
ttacaaccac agcacccatt acgcaatggc ggtctggcag ttaggacaag ccgtggcgct 180
ggcgcgagta cagtagctat ttacaagagg ggggcgtgag cttccctctg gctaatcagc 240
ttttttctga atcctcctcg taaaattgca acgccaacac catcttcctg acgaaagtgc 300
tatcttgtcc ggcataaatt tttgactgac agaggttgtg atgactgaca gtgacaaaac 360
acttgatact gtatgagcat acagtataat tacttcaaca gaacatattg actatccggt 420
attacccggc atgacaggag taaaaatggc tatcgacgaa aacaaacaga aagcgttggc 480
ggcagcactg ggccagattg agaaacaatt tggtaaaggc tccatcatgc gcctgggtga 540
agaccgttcc atggatgtgg aaaccatctc taccggttcg ctttcactgg atatcgcgct 600
tggggcaggt ggtctgccga tgggccgtat cgtcgaaatc tacggaccgg aatcttccgg 660
taaaaccacg ctgacgttgc aggtgatcgc cgcagcgcag cgtgaaggac tgagactgat 720
gtccta 726
<210> 9
<211> 529
<212> DNA
<213> 人工序列
<400> 9
ctactcgagc gtcgcatcag gcattgagca ccgaatgccg gatacggcgt gaacgccttt 60
tccggcctac aacagcctta gtatccgcaa tttcgtagcg ggtcacccgt gcaggttttt 120
tcaaaccttg tttaatctcg acagcctctt tcagagaggt tttcaactca tcaaaaaact 180
tattttatac ctcgcctttg agccgtttca tcgcggttat ctctgctccc ccatcatctc 240
ccgcaccagc tccacgcagc gcaggaaacg gctgtcataa tcgtcctctt caacccgcac 300
gaattcgata ttgttctcga tggcagtttt caggtaatca aatgacgaca tatctccctc 360
cgtatctctc attataagtc gtcgaacacg ctaagcgcgt cggagagttt tttaacgcca 420
aaaatctgca tcccttccgg cgcttttttc ggtacgttag ccgccggaac aatcgcccgg 480
cgaaaaccgt gtttcgccgc ttctgaaatt cgttccgact gatgtcatc 529
<210> 10
<211> 1141
<212> DNA
<213> 人工序列
<400> 10
tcagccaaac gtctcttcag gccactgact agcgataact ttccccacaa cggaacaact 60
ctcattgcat gggatcattg ggtactgtgg gtttagtggt tgtaaaaaca cctgaccgct 120
atccctgatc agtttcttga aggtaaactc atcaccccca agtctggcta tgcagaaatc 180
acctggctca acagcctgct cagggtcaac gagaattaac attccgtcag gaaagcttgg 240
cttggagcct gttggtgcgg tcatggaatt accttcaacc tcaagccaga atgcagaatc 300
actggctttt ttggttgtgc ttacccatct ctccgcatca cctttggtaa aggttctaag 360
ctcaggtgag aacatccctg cctgaacatg agaaaaaaca gggtactcat actcacttct 420
aagtgacggc tgcatactaa ccgcttcata catctcgtag atttctctgg cgattgaagg 480
gctaaattct tcaacgctaa ctttgagaat ttttgcaagc aatgcggcgt tataagcatt 540
taatgcattg atgccattaa ataaagcacc aacgcctgac tgccccatcc ccatcttgtc 600
tgcgacagat tcctgggata agccaagttc atttttcttt ttttcataaa ttgctttaag 660
gcgacgtgcg tcctcaagct gctcttgtgt taatggtttc ttttttgtgc tcatacgtta 720
aatctatcac cgcaagggat aaatatctaa caccgtgcgt gttgactatt ttacctctgg 780
cggtgataat ggttgcatgt actaaggagg ttgtatggaa caacgcataa ccctgaaaga 840
ttatgcaatg cgctttgggc aaaccaagac agctaaaaga tctctcacct accaaacaat 900
gcccccctgc aaaaaataaa ttcatataaa aaacatacag ataaccatct gcggtgataa 960
attatctctg gcggtgttga cataaatacc actggcggtg atactgagca catcagcagg 1020
acgcactgac caccatgaag gtgacgctct taaaaattaa gccctgaaga agggcagcat 1080
tcaaagcaga aggctttggg gtgtgtgata cgaaacgaag cattggttaa aaattaagga 1140
g 1141
<210> 11
<211> 1488
<212> DNA
<213> 人工序列
<400> 11
atggacaacc tgctgaacta tagcagccgt gcgagcgcga tcccgagcct gctgtgcgat 60
ttctacaaga ccagccaccg tattatgtat ccggagtgca gccagatcat ttacagcacc 120
tttaccccgc gtagcaacga acaggcgccg tacctgaccc tagtggttag cttcggtttt 180
caagcgttca tcatcaagta cctgatccac tacttcaacg acaacttctt tagccgtgac 240
aagcacgatg tggttaccga gtatagcgcg ttcatcgaaa aaaccctgca actggaggat 300
accggtgaac acattgcgaa gctgcacgag ctgggctacc tgccgatccg tattaaagcg 360
atcccggaag gcaagaccgt ggcgatcaaa gtgccggtta tgaccattga gaacacccac 420
agcgacttct tttggctgac caactatctg gaaaccctga ttaacgttag cctgtggcaa 480
ccgatgacca gcgcgagcat cgcgttcgcg taccgtaccg cgctgattaa gtttgcgaac 540
gagacctgcg acaaccagga acacgtgccg ttccaaagcc acgattttag catgcgtggt 600
atgagcagcc tggagagcgc ggaaaccagc ggtgcgggtc acctgaccag cttcctgggc 660
accgacacca tcccggcgct gagctttgtt gaggcgtact atggtagcag cagcctgatc 720
ggcaccagca ttccggcgag cgagcacagc gtgatgagca gccacggtgt tgatgaactg 780
agcaccttcc gttatctgat ggcgaagttt ccgcacaaca tgctgagcat cgtgagcgac 840
accaccgatt tctggcacaa cattaccgtt aacctgccgc tgctgaaaca ggagatcatt 900
gcgcgtccgg aaaacgcgcg tctggtgatc cgtccggaca gcggtaactt ctttgcgatc 960
atttgcggcg acccgaccgc ggataccgag cacgagcgta agggtctgat cgaatgcctg 1020
tgggacattt tcggtggcac cgtgaaccag aagggttata aagttattaa cccgcacatc 1080
ggcgcgattt acggtgatgg cgttacctat gagaagatgt ttaaaatcct ggaaggtctg 1140
caagcgaaag gcttcgcgag cagcaacatt gtgtttggtg ttggcgcgca gacctaccaa 1200
cgtaacaccc gtgacaccct gggtttcgcg ctgaaggcga ccagcatcac cattaacggc 1260
gaggaaaaag cgatcttcaa gaacccgaaa accgacgatg gttttaagaa aagccagaag 1320
ggccgtgtga aagttctgag ccgtgacacc tacgtgggtg gtctgaccag cgcggacgat 1380
ttcagcgacg atctgctgga gctgctgttt gaagatggca aactgctgcg tcagaccgac 1440
tttgatgaga tccgtcaaaa cctgctggtt agccgtacca ccctgtaa 1488
<210> 12
<211> 495
<212> PRT
<213> 人工序列
<400> 12
Met Asp Asn Leu Leu Asn Tyr Ser Ser Arg Ala Ser Ala Ile Pro Ser
1 5 10 15
Leu Leu Cys Asp Phe Tyr Lys Thr Ser His Arg Ile Met Tyr Pro Glu
20 25 30
Cys Ser Gln Ile Ile Tyr Ser Thr Phe Thr Pro Arg Ser Asn Glu Gln
35 40 45
Ala Pro Tyr Leu Thr Leu Val Val Ser Phe Gly Phe Gln Ala Phe Ile
50 55 60
Ile Lys Tyr Leu Ile His Tyr Phe Asn Asp Asn Phe Phe Ser Arg Asp
65 70 75 80
Lys His Asp Val Val Thr Glu Tyr Ser Ala Phe Ile Glu Lys Thr Leu
85 90 95
Gln Leu Glu Asp Thr Gly Glu His Ile Ala Lys Leu His Glu Leu Gly
100 105 110
Tyr Leu Pro Ile Arg Ile Lys Ala Ile Pro Glu Gly Lys Thr Val Ala
115 120 125
Ile Lys Val Pro Val Met Thr Ile Glu Asn Thr His Ser Asp Phe Phe
130 135 140
Trp Leu Thr Asn Tyr Leu Glu Thr Leu Ile Asn Val Ser Leu Trp Gln
145 150 155 160
Pro Met Thr Ser Ala Ser Ile Ala Phe Ala Tyr Arg Thr Ala Leu Ile
165 170 175
Lys Phe Ala Asn Glu Thr Cys Asp Asn Gln Glu His Val Pro Phe Gln
180 185 190
Ser His Asp Phe Ser Met Arg Gly Met Ser Ser Leu Glu Ser Ala Glu
195 200 205
Thr Ser Gly Ala Gly His Leu Thr Ser Phe Leu Gly Thr Asp Thr Ile
210 215 220
Pro Ala Leu Ser Phe Val Glu Ala Tyr Tyr Gly Ser Ser Ser Leu Ile
225 230 235 240
Gly Thr Ser Ile Pro Ala Ser Glu His Ser Val Met Ser Ser His Gly
245 250 255
Val Asp Glu Leu Ser Thr Phe Arg Tyr Leu Met Ala Lys Phe Pro His
260 265 270
Asn Met Leu Ser Ile Val Ser Asp Thr Thr Asp Phe Trp His Asn Ile
275 280 285
Thr Val Asn Leu Pro Leu Leu Lys Gln Glu Ile Ile Ala Arg Pro Glu
290 295 300
Asn Ala Arg Leu Val Ile Arg Pro Asp Ser Gly Asn Phe Phe Ala Ile
305 310 315 320
Ile Cys Gly Asp Pro Thr Ala Asp Thr Glu His Glu Arg Lys Gly Leu
325 330 335
Ile Glu Cys Leu Trp Asp Ile Phe Gly Gly Thr Val Asn Gln Lys Gly
340 345 350
Tyr Lys Val Ile Asn Pro His Ile Gly Ala Ile Tyr Gly Asp Gly Val
355 360 365
Thr Tyr Glu Lys Met Phe Lys Ile Leu Glu Gly Leu Gln Ala Lys Gly
370 375 380
Phe Ala Ser Ser Asn Ile Val Phe Gly Val Gly Ala Gln Thr Tyr Gln
385 390 395 400
Arg Asn Thr Arg Asp Thr Leu Gly Phe Ala Leu Lys Ala Thr Ser Ile
405 410 415
Thr Ile Asn Gly Glu Glu Lys Ala Ile Phe Lys Asn Pro Lys Thr Asp
420 425 430
Asp Gly Phe Lys Lys Ser Gln Lys Gly Arg Val Lys Val Leu Ser Arg
435 440 445
Asp Thr Tyr Val Gly Gly Leu Thr Ser Ala Asp Asp Phe Ser Asp Asp
450 455 460
Leu Leu Glu Leu Leu Phe Glu Asp Gly Lys Leu Leu Arg Gln Thr Asp
465 470 475 480
Phe Asp Glu Ile Arg Gln Asn Leu Leu Val Ser Arg Thr Thr Leu
485 490 495
Claims (10)
1.一种烟酸磷酸核糖转移酶突变体，其特征在于，所述突变体氨基酸序列如序列表SEQID NO:12所示。
2.权利要求1所述烟酸磷酸核糖转移酶突变体的编码基因。
3.一株生产NMN的大肠杆菌基因工程菌，其特征在于，所述工程菌是在大肠杆菌宿主中，通过缺失对烟酰胺核苷酸酰胺酶编码基因pncC、烟酰胺单核苷酸腺苷转移酶基因nadD、nadR的表达的同时，过表达NAD+合酶编码基因nadE；表达烟酸磷酸核糖转移酶突变体编码基因NadVmu、核糖磷酸二磷酸激酶编码基因Prs以及核糖激酶编码基因RbsK获得的。
4.如权利要求3一株生产NMN的大肠杆菌基因工程菌，其特征在于，pncC、nadR基因缺失表达的方式为基因敲除；nadD基因缺失表达的方式为通过CIts蛋白及PR/PL启动子温敏控制表达。
5.如权利要求3一株生产NMN的大肠杆菌基因工程菌，其特征在于，pncC基因的核苷酸序列如序列表SEQ ID NO：2所示；nadD基因的核苷酸序列如序列表SEQ ID NO：3所示；nadR基因的核苷酸序列如序列表SEQ ID NO：4所示；nadE基因的核苷酸序列如序列表SEQ IDNO：5所示；Prs基因的核苷酸序列如序列表SEQ ID NO：6所示；RbsK基因的核苷酸序列如序列表SEQ ID NO：7所示；烟酸磷酸核糖转移酶突变体编码基因NadVmu的核苷酸序列如序列表SEQ ID NO：11所示。
6.如权利要求3一株生产NMN的大肠杆菌基因工程菌，其特征在于，所述大肠杆菌宿主选自JM109、BL21(DE3)、Top 10、DH5α、Rosetta、或Rosetta-gami pLysS。
7.如权利要求3一株生产NMN的大肠杆菌基因工程菌，其特征在于，是以大肠杆菌JM109为宿主，通过敲除pncC、nadR基因，CIts蛋白及PR/PL启动子温敏控制nadD基因表达，采用pET-28a载体对nadE基因进行过表达，采用pGEX4T3载体对NadV、Prs、RbsK基因进行过表达获得。
8.权利要求3-8任一所述大肠杆菌基因工程菌在生产NMN中的应用。
9.如权利要求8所述的应用，其特征在于，采用上述工程菌发酵生产NMN的方法如下：
反应体系包括：烟酰胺5-20mmol/L、核糖10-20mmol/L、ATP 5-10mmol/L、NAD+5-10mmol/L、Na2HPO4/NaH2PO4 50mmol/L、醋酸钠10mmol/L、氯化钙1mmol/L，其余为水pH5-8.5；加入生产菌使菌体浓度达到5-100g/L，在15-22℃，50-200rpm，避光下反应10-25h。
10.如权利要求9所述的应用，其特征在于，菌体培养方法如下：
将工程菌种子液接种于培养基中，37℃、200rpm培养至OD600为0.7，自来水冷却10min，加1mM IPTG后，22℃、200rpm条件下诱导表达24h；离心收集菌体。
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210408487.1A CN114807078B (zh) | 2022-04-19 | 2022-04-19 | 一种生物合成nmn的方法 |
| PCT/CN2023/081819 WO2023202281A1 (zh) | 2022-04-19 | 2023-03-16 | 一种生物合成nmn的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210408487.1A CN114807078B (zh) | 2022-04-19 | 2022-04-19 | 一种生物合成nmn的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114807078A true CN114807078A (zh) | 2022-07-29 |
| CN114807078B CN114807078B (zh) | 2023-09-01 |
Family
ID=82505371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210408487.1A Active CN114807078B (zh) | 2022-04-19 | 2022-04-19 | 一种生物合成nmn的方法 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN114807078B (zh) |
| WO (1) | WO2023202281A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023202281A1 (zh) * | 2022-04-19 | 2023-10-26 | 四川盈嘉合生科技有限公司 | 一种生物合成nmn的方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105755019A (zh) * | 2016-03-07 | 2016-07-13 | 华南师范大学 | 一种烟酰胺单核苷酸腺苷酰转移酶基因及其应用 |
| US20170058270A1 (en) * | 2015-08-27 | 2017-03-02 | The Procter & Gamble Company | Bifidobacterium longum |
| US20190071680A1 (en) * | 2016-03-16 | 2019-03-07 | Dsm Ip Assets B.V. | Microbial production of nicotinic acid riboside |
| CN109666658A (zh) * | 2018-12-27 | 2019-04-23 | 成都及禾生物科技有限公司 | 用于制备nmn的烟酰胺磷酸核糖转移酶、编码基因、重组载体及应用 |
| CN111051520A (zh) * | 2017-09-29 | 2020-04-21 | 三菱化学株式会社 | 烟酰胺单核苷酸的制造方法及该方法所使用的转化体 |
| WO2020129997A1 (ja) * | 2018-12-18 | 2020-06-25 | 帝人株式会社 | ニコチンアミド誘導体を製造するための組換え微生物及び方法、並びにそれに用いられるベクター |
| CN111718915A (zh) * | 2020-06-16 | 2020-09-29 | 仙居两山生物科技有限公司 | 一种烟酰胺磷酸核糖转移酶突变体、包含该突变体的重组表达载体和重组菌及应用 |
| CN113755413A (zh) * | 2020-06-04 | 2021-12-07 | 苏州华赛生物工程技术有限公司 | 生产β-烟酰胺单核苷酸的重组微生物及其生产NMN的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020123563A1 (en) * | 2018-12-10 | 2020-06-18 | The Regents Of The University Of California | Engineered polypeptides that exhibit increased catalytic efficiency for unnatural cofactors and uses thereof |
| CN110373397B (zh) * | 2019-08-06 | 2022-10-21 | 江苏诚信药业有限公司 | 一种烟酰胺磷酸核糖转移酶突变体及其应用 |
| CN113106080B (zh) * | 2021-03-31 | 2022-02-25 | 深圳希吉亚生物技术有限公司 | 烟酰胺磷酸核糖转移酶突变体及其应用 |
| CN114807078B (zh) * | 2022-04-19 | 2023-09-01 | 四川盈嘉合生科技有限公司 | 一种生物合成nmn的方法 |
-
2022
- 2022-04-19 CN CN202210408487.1A patent/CN114807078B/zh active Active
-
2023
- 2023-03-16 WO PCT/CN2023/081819 patent/WO2023202281A1/zh unknown
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170058270A1 (en) * | 2015-08-27 | 2017-03-02 | The Procter & Gamble Company | Bifidobacterium longum |
| CN105755019A (zh) * | 2016-03-07 | 2016-07-13 | 华南师范大学 | 一种烟酰胺单核苷酸腺苷酰转移酶基因及其应用 |
| US20190071680A1 (en) * | 2016-03-16 | 2019-03-07 | Dsm Ip Assets B.V. | Microbial production of nicotinic acid riboside |
| CN111051520A (zh) * | 2017-09-29 | 2020-04-21 | 三菱化学株式会社 | 烟酰胺单核苷酸的制造方法及该方法所使用的转化体 |
| US20200332332A1 (en) * | 2017-09-29 | 2020-10-22 | Mitsubishi Chemical Corporation | Method for Producing Nicotinamide Mononucleotide and Transformant Used in Said Method |
| WO2020129997A1 (ja) * | 2018-12-18 | 2020-06-25 | 帝人株式会社 | ニコチンアミド誘導体を製造するための組換え微生物及び方法、並びにそれに用いられるベクター |
| CN109666658A (zh) * | 2018-12-27 | 2019-04-23 | 成都及禾生物科技有限公司 | 用于制备nmn的烟酰胺磷酸核糖转移酶、编码基因、重组载体及应用 |
| CN113755413A (zh) * | 2020-06-04 | 2021-12-07 | 苏州华赛生物工程技术有限公司 | 生产β-烟酰胺单核苷酸的重组微生物及其生产NMN的方法 |
| CN111718915A (zh) * | 2020-06-16 | 2020-09-29 | 仙居两山生物科技有限公司 | 一种烟酰胺磷酸核糖转移酶突变体、包含该突变体的重组表达载体和重组菌及应用 |
Non-Patent Citations (1)
| Title |
|---|
| 苟冬梅;梁丽亚;刘嵘明;张常青;吴明科;马江锋;陈可泉;朱建国;姜岷;: "过量表达烟酸单核苷酸腺苷酰转移酶对大肠杆菌NZN111产丁二酸的影响", 生物工程学报, no. 09 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023202281A1 (zh) * | 2022-04-19 | 2023-10-26 | 四川盈嘉合生科技有限公司 | 一种生物合成nmn的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023202281A1 (zh) | 2023-10-26 |
| CN114807078B (zh) | 2023-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102074957B1 (ko) | 타가토스 생산용 조성물 및 이를 이용한 타가토스 제조방법 | |
| CA2595873C (en) | Dna fragment encoding an enzyme having polyphosphate-driven adp phosphorylation activity | |
| CN107604023A (zh) | 岩藻糖基转移酶及其应用 | |
| MX2013004055A (es) | Nuevas fucosiltransferasas y sus aplicaciones. | |
| CN112795551B (zh) | 一种耐高温逆转录酶突变体及其应用 | |
| CN112280762A (zh) | 一种烟酰胺核糖激酶突变体及其编码基因和应用 | |
| CN108103039B (zh) | 一组岩藻糖基转移酶突变体及其筛选方法和应用 | |
| CN110699373A (zh) | 尿苷二磷酸葡萄糖高产菌株及其应用 | |
| CN114807078B (zh) | 一种生物合成nmn的方法 | |
| CN114231477B (zh) | 高产β-烟酰胺单核苷酸的基因工程菌株及其构建与应用 | |
| KR20200010285A (ko) | 증가된 nadph를 유도하는 생합성 경로의 게놈 공학 | |
| EP4273224A1 (en) | Recombinant microorganism, preparation method therefor, and application of recombinant microorganism in production of tagatose | |
| Taran et al. | Enzymatic transglycosylation of natural and modified nucleosides by immobilized thermostable nucleoside phosphorylases from Geobacillus stearothermophilus | |
| CN111041018A (zh) | 支链酮糖的生物合成方法 | |
| JPWO2004009830A1 (ja) | Ｃｍｐ−ｎ−アセチルノイラミン酸の製造法 | |
| CN108424943B (zh) | 一种生产2’-脱氧-2’-氟-β-D-阿拉伯糖腺苷酸的方法 | |
| JP3833584B2 (ja) | Ｃｍｐ−ｎ−アセチルノイラミン酸の製造法 | |
| CN112795549B (zh) | 一种逆转录酶突变体 | |
| CN113637652A (zh) | 一种腺苷转移酶突变体及其应用 | |
| KR20100053294A (ko) | 신규 ｌ-아라비노스 이성화효소 및 이를 이용한 ｌ-리불로스의 생산방법 | |
| WO2018180568A1 (ja) | 変異型２－デオキシ－シロ－イノソース合成酵素 | |
| CN111057697A (zh) | 耐高温TIM barrel蛋白突变体及其应用 | |
| JP5068956B2 (ja) | デオキシリボヌクレオシド一リン酸からのデオキシリボヌクレオシド三リン酸の製造方法 | |
| WO2013065901A1 (ko) | 이중 조효소 특이성을 갖는 리비톨 탈수소화효소 및 그의 용도 | |
| CN114164189B (zh) | 一种烟酰胺磷酸核糖转移酶突变体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for biosynthesis of NMN Granted publication date: 20230901 Pledgee: Industrial Bank Limited by Share Ltd. Chengdu branch Pledgor: SICHUAN INGIA BIOSYNTHETIC Co.,Ltd. Registration number: Y2024980008649 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |